CA3290846A1 - Traitement de la sclérose en plaques à l'aide d'une thérapie génique nt-3 - Google Patents

Traitement de la sclérose en plaques à l'aide d'une thérapie génique nt-3

Info

Publication number
CA3290846A1
CA3290846A1 CA3290846A CA3290846A CA3290846A1 CA 3290846 A1 CA3290846 A1 CA 3290846A1 CA 3290846 A CA3290846 A CA 3290846A CA 3290846 A CA3290846 A CA 3290846A CA 3290846 A1 CA3290846 A1 CA 3290846A1
Authority
CA
Canada
Prior art keywords
treatment
gene therapy
multiple sclerosis
sclerosis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3290846A
Other languages
English (en)
Inventor
Zarife Sahenk
Original Assignee
Nationwide Childrens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nationwide Childrens Hospital Inc filed Critical Nationwide Childrens Hospital Inc
Publication of CA3290846A1 publication Critical patent/CA3290846A1/fr
Pending legal-status Critical Current

Links

CA3290846A 2023-05-02 2024-05-01 Traitement de la sclérose en plaques à l'aide d'une thérapie génique nt-3 Pending CA3290846A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/463,501 2023-05-02

Publications (1)

Publication Number Publication Date
CA3290846A1 true CA3290846A1 (fr) 2024-11-07

Family

ID=

Similar Documents

Publication Publication Date Title
CA3290846A1 (fr) Traitement de la sclérose en plaques à l'aide d'une thérapie génique nt-3
CA3283887A1 (fr) Thérapie génique pour le traitement de la douleur
CA3265741A1 (fr) Traitement par thérapie génique
WO2023102227A9 (fr) Traitement de maladies neurologiques à l'aide de modulateurs de transcrits de gène smn2
HK40119153A (en) Plakophillin-2 gene therapy treatment methods
EP4081232A4 (fr) Systèmes de thérapie génique et méthodes associées pour le traitement d'une perte de l'audition
CA3306404A1 (fr) Brincidofovir pour le traitement de la sclérose en plaques
HK40121510A (en) Gene therapy for the treatment of cognitive disorders
HK40118081A (en) Treatment of neurological diseases using modulators of unc13a gene transcripts
HK40084393A (en) Gene therapy treatment
HK40121133A (en) Treatment of depression
HK40117553A (en) Treatment of cervical dystonia
CA3290995A1 (fr) Thérapie génique
CA3286101A1 (fr) Thérapie génique
CA3269758A1 (fr) Thérapie génique avec le bdnf
CA3264521A1 (fr) Thérapie génique
CA3274078A1 (fr) Traitement de la douleur induite par les opioïdes
HK40130651A (en) Treatment of opiod-induced pain
HK40117651A (en) Gene therapy methods for treatment of diabetes
HK40108535A (en) Combination treatment methods of multiple sclerosis
CA3264674A1 (fr) Traitement de la fasciolose
AU2024902833A0 (en) Treatment of diseases associated with mitophagy
HK40085402A (en) Method of treating gene therapy associated toxicity with antibiotics
CA3303437A1 (fr) Traitement de la leucodystrophie
AU2023902382A0 (en) Methods of treatment